MedPath

GLICLAZIDA COMBIX 30 MG COMPRIMIDOS DE LIBERACION MODIFICADA EFG

GLICLAZIDA COMBIX 30 MG COMPRIMIDOS DE LIBERACION MODIFICADA EFG

Pending
Register Number

82907

Prescription Type

Medicamento Sujeto A Prescripción Médica. Tratamiento De Larga Duración

Authorization Date

Feb 27, 2018

Dosage Form

COMPRIMIDO DE LIBERACIÓN MODIFICADA

Route: VÍA ORAL

Product Details

Detailed information about this CIMA AEMPS approved pharmaceutical product.

Basic Information

Key regulatory and product classification details

Regulatory Details

Register Number82907
EMA Approved
No

Drug Classification

Generic
Yes
Orphan
No
Biosimilar
No
Commercialized
No
CIMA AEMPS Classification

INGREDIENTS (1)

GLICLAZIDAActive
Quantity: 30,000 mg
Name: GLICLAZIDA

ATC CLASSIFICATION (3)

A10B
A10BB
A10BB09

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.